Treatment of swelling of voice box with Unani medicine Habb-e Khunaq
Phase 3
- Conditions
- Health Condition 1: J040- Acute laryngitis
- Registration Number
- CTRI/2023/01/049200
- Lead Sponsor
- Central Council for Research in Unani Medicine CCRUM New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients of either sex in the age group of 18-60 years.
2. Presence of all of the following signs and symptoms of Waram-i-Hanjara (Laryngitis)
Hoarseness.
Weak voice or discomfort in speaking-dysphonia
Tickling sensation and rawness in your throat
Globus pharyngeus (feeling of a lump in the throat)
Sore throat
Dry throat
Dry cough
Exclusion Criteria
1. Loss of voice (aphonia)
2. Dysphagia, odynophagia
3. History of fever morethan 380 C
4. Known cases of Renal/ Hepatic/ Cardiac ailments/ Diabetes mellitus
5. Pregnant and lactating women
6. Chronic alcoholic and smokers
7. Gastro esophageal reflux
8. Spasmodic dysphonia
9. Reflux laryngitis, Chronic allergic laryngitis, Epiglottitis
10. Known case of any type of Neoplasms
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The efficacy of the study drug will be assessed on the basis of improvement in Hoarseness and other symptoms. Hoarsness will be assessed by GRBAS scale. The other symptoms (Weak voice or discomfort in speaking-dysphonia, Tickling sensation and rawness in throat, Globus pharyngeus (feeling of a lump in the throat), Sore throat, Dry throat, Dry cough) will be assessed using the Visual Analogue Scale (VAS).Timepoint: At baseline, 3rd and 7th day
- Secondary Outcome Measures
Name Time Method Haematological and biochemical assessment for safety assessment Timepoint: Investigations will be done at baseline and end of treatment